Diabetes Intervention Involving Person-centred Nutritional Education
DINE
1 other identifier
interventional
54
1 country
1
Brief Summary
The overall objective for this project is to evaluate the effects of a person-centred education intervention to promote a healthy, sustainable Nordic diet compared with the current practice of providing short dietary information on health outcomes of adults with Type 1 diabetes. The study will measure the intervention's impact on blood glucose levels, blood lipids, blood pressure, and adherence to a sustainable and healthy Nordic diet. The main question the trial aims to answer is: Does a person-centred nutritional education have an impact on glucose time in range for adults with Type 1 diabetes, compared with short dietary information? The participants will:
- Attend either a person-centred nutrition education (intervention) or receive short dietary information (control group).
- Wear their sensor for continuous glucose monitoring (CGM) throughout the trial.
- Visit the clinic for data collection (blood samples and clinical checks) at the start and end of the trial.
- Keep a four-day food diary, fill out a food frequency questionnaire (FFQ) and estimate their food enjoyment at the start and end of the trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
December 12, 2025
December 1, 2025
1.7 years
November 20, 2025
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time in range - Percentage of time spent with blood glucose levels between 3.9-10 mmol/l.
Percentage of time spent with glucose levels between 3.9-10 mmol/l measured with continuous glucose monitor (CGM) over 10-14 days.
Week 1, 12 and 24.
Secondary Outcomes (6)
Adherence to a Nordic diet.
Week 1 and 24.
Glycosylated Hemoglobin (HbA1c).
Week 1 and 24.
Time above range - percentage of time spent with blood glucose levels above 10.0 mmol/L and 13.9 mmol/L respectively.
Week 1, 12 and 24.
Time below range - percentage of time spent with blood glucose levels below 3.9 mmol/L and 3.0 mmol/L respectively.
Week 1, 12 and 24.
Blood lipids.
Week 1 and 24.
- +1 more secondary outcomes
Study Arms (2)
Person-centred nutritional education
EXPERIMENTALThe participants in this arm will attend a person-centred intervention involving a pre-assessment focused on creating partnership in care. This is followed by a nutrition education session on the healthy Nordic diet, and a series of follow-up measures.
Short dietary information
NO INTERVENTIONThe participants in this arm will receive short dietary information (brochure) at the same level as standard care.
Interventions
A person-centred education focussed on creating partnerships in care and shared decision-making.
Eligibility Criteria
You may qualify if:
- Type 1 Diabetes.
- Diabetes duration for more than 12 months at screening.
- Adults 18 years or older.
- HbA1c more than 57mmol/mol.
- Use of continuous glucose monitoring (CGM) sensor for more than three months at screening and during the study period.
- Use of basal and bolus insulin regimen for more than three months at screening and during the study period.
- Written Informed Consent.
You may not qualify if:
- Women of childbearing potential: ongoing pregnancy or planned pregnancy during the study period.
- Cognitive impairment or other disease that study physician find non-compatible with participation.
- Planned change in glucose lowering treatment during study period (change of mealtime insulin analogue with same pharmacodynamic profile allowed).
- Planned change of CGM sensor during the study.
- Food allergies or intolerances that are incompatible with adhering to Nordic nutrition recommendations.
- Current or planned treatment with corticosteroids during the study (other than for replacement therapy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
- Lasarettet i Enköpingcollaborator
Study Sites (1)
Hospital of Enköping
Enköping, Uppland, 74525, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth Stoltz Sjöström, Associate professor
Department of Food, Nutrition and Culinary Science, Umeå University, Sweden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- As the participants are actively involved in the education intervention, it is not possible to have a blinded trial, however each group will not receive information about the alternative group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 2, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share